Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

69 trials with published results (8%)

Research Maturity

483 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.4%

44 terminated out of 822 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

17%

136 trials in Phase 3/4

Results Transparency

14%

69 of 483 completed with results

Key Signals

69 with results92% success44 terminated

Data Visualizations

Phase Distribution

512Total
Not Applicable (262)
Early P 1 (9)
P 1 (42)
P 2 (63)
P 3 (74)
P 4 (62)

Trial Status

Completed483
Unknown128
Recruiting84
Not Yet Recruiting49
Terminated44
Withdrawn17

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 483 completed trials

Clinical Trials (822)

Showing 20 of 20 trials
NCT07634419Not ApplicableNot Yet Recruiting

Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress: the Lift RCT

NCT07631377Phase 4Not Yet RecruitingPrimary

The LalelaLung Study: Digital Stethoscope Clinical Evaluation

NCT00077909RecruitingPrimary

Study of Lung Proteins in Patients With Pneumonia

NCT04365101Phase 1Terminated

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

NCT07530146Phase 3Recruiting

Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

NCT07612605Early Phase 1Not Yet RecruitingPrimary

Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia

NCT07615010Phase 2RecruitingPrimary

A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure

NCT00006150Recruiting

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

NCT07604103Phase 3Recruiting

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

NCT06950294Early Phase 1Recruiting

iNO300 Therapy in Critically Ill Patients With Pneumonia

NCT07453966Not ApplicableRecruitingPrimary

Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation

NCT07601711Recruiting

Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study

NCT06526884Not ApplicableCompletedPrimary

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

NCT07586345Not ApplicableNot Yet RecruitingPrimary

The Effectiveness of Different Nebulized Solutions on Airway Clearance Function in Patients With Pneumonia

NCT05336851Recruiting

Emergency PWAS in Respiratory Infectious Disease

NCT05452941RecruitingPrimary

A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting

NCT07574866Not Yet RecruitingPrimary

A Retrospective Study on Clinical Characteristics and Outcomes of Patients With Pneumonia

NCT07426718Recruiting

A Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Volunteers.

NCT07567911Not Yet Recruiting

A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia

NCT05041140Recruiting

Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment

Scroll to load more

Research Network

Activity Timeline